http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-102019021511-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e078efe4739e86ce939ab69a84c1c5b1 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 |
| filingDate | 2019-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53196b66de3901aa47d10a442b1dd2b1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4cb291afdfb57e3e87bcdfa9df116495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5e8e27b6924bd6803d0b4109e839d60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0afe28dfdffdcb13fdf6248fe4b42ba7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_425eb502bcfc1576b1735d41db17cbd0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9eb7d70647d456378e33f04dff926a5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90c1c271cbb7a453c25e73126ce1e859 |
| publicationDate | 2022-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-102019021511-A2 |
| titleOfInvention | Production method of toxocara canis recombinant proteins, targeted as a vaccine to control canine toxocariasis |
| abstract | method of production of toxocara canis recombinant proteins, targeted as a vaccine to control canine toxocariasis. the present invention relates to the production methodology of the recombinant proteins rtccad and rtcvcan from toxocara canis as effective antigens for use as a vaccine in the control of infection in domestic and stray dogs. the proposed method allows the production of recombinant proteins of toxocara canis in a heterologous system that will be used as a vaccine with low production cost, and capable of generating effective protection against the parasite, controlling the infection in animals and indirectly in humans. the proposed methodology will have a low cost of obtaining, purifying and producing on a large scale the recombinant antigens that will constitute the canine anti-toxocariasis vaccine. |
| priorityDate | 2019-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 214.